These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 46529)

  • 41. Mild familial diabetes with dominant inheritance.
    Tattersall RB
    Q J Med; 1974 Apr; 43(170):339-57. PubMed ID: 4212169
    [No Abstract]   [Full Text] [Related]  

  • 42. Guar and diabetes.
    Goulder TJ
    Lancet; 1979 Mar; 1(8116):612. PubMed ID: 85199
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of glibenclamide in maturity-onset diabetics as maintenance therapy.
    Ahuja MM; Gupta SP; Sehgel VK
    Horm Metab Res; 1973 May; 5(3):160-3. PubMed ID: 4197503
    [No Abstract]   [Full Text] [Related]  

  • 44. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR; Wragg KG; Shetty KT; Biggs PI; Davies CD
    Horm Metab Res; 1979 Jun; 11(6):411-2. PubMed ID: 112018
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison between the action of chlorpropamide and an association of chlorpropamide with metformin on the daily fluctuations of glucose and insulin in diabetics].
    Berger W; Goschke H; Denes A
    J Med Lyon; 1972 Feb; 53(222):168 passim. PubMed ID: 5046641
    [No Abstract]   [Full Text] [Related]  

  • 46. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet.
    Clarke BF; Campbell IW
    Br Med J; 1977 Dec; 2(6102):1576-8. PubMed ID: 589351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
    Pitucco G; Caputo V; Santucci A; Daniele E; De Mattia G; De Angelis A
    Clin Ter; 1978 Jun; 85(6):550-8. PubMed ID: 97042
    [No Abstract]   [Full Text] [Related]  

  • 49. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IRI-secretion in MOD with and without SU (5 year control).
    Lohmann D; Verlohren HJ
    Horm Metab Res; 1980 Dec; 12(12):702-3. PubMed ID: 6782002
    [No Abstract]   [Full Text] [Related]  

  • 51. [Insulin plus sulphonyl-urea compounds in the treatment of diabetes mellitus of the maturity-onset type (author's transl)].
    Traumann KJ; Hösl W; Grom E; Wittemann G
    Dtsch Med Wochenschr; 1982 Feb; 107(5):180-4. PubMed ID: 6799267
    [No Abstract]   [Full Text] [Related]  

  • 52. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience].
    Contreras AR; Gabrielli S; Baigorria L
    Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172
    [No Abstract]   [Full Text] [Related]  

  • 53. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M
    Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
    [No Abstract]   [Full Text] [Related]  

  • 54. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 55. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Dietary treatment of maturity-onset diabetes mellitus.
    Anderson J; Lind T; Billewicz WZ
    Lancet; 1975 Aug; 2(7928):277. PubMed ID: 49818
    [No Abstract]   [Full Text] [Related]  

  • 57. [Role of glibenclamide in the therapy of diabetes].
    Parodi FA
    Minerva Med; 1972 Apr; 63(28):1629-32. PubMed ID: 4623326
    [No Abstract]   [Full Text] [Related]  

  • 58. [Various problems in diabetes: from the symposium of the 18th Congress of the Japanese Association of Medical Sciences].
    Yamada K; Abe M; Yamashita K; Murachi T; Shimada N
    Nihon Ishikai Zasshi; 1971 Aug; 66(3):247-60. PubMed ID: 4398768
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chlorpropamide-induced hyponatremia: incidence and risk factors.
    Kadowaki T; Hagura R; Kajinuma H; Kuzuya N; Yoshida S
    Diabetes Care; 1983; 6(5):468-71. PubMed ID: 6443808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.